On the annual disclosed figures, sales rose from KRW 760.5 billion in 2022 to KRW 859.6 billion in 2023 (up 13.0%) and KRW 1.02 trillion in 2024 (up 18.3%), then held at KRW 1.02 trillion in 2025.
Operating profit went from KRW 56.6 billion in 2022 to KRW 68.3 billion in 2023 (up 20.6%) and KRW 70.5 billion in 2024 (up 3.2%), then fell 7.7% to KRW 65.1 billion in 2025. The operating margin was 7.4% in 2022, 7.9% in 2023, 6.9% in 2024 and 6.4% in 2025, so it peaked in 2023 and has declined since.
Net income attributable to controlling shareholders was KRW 69.6 billion in 2024, up 73.2%, the largest of the 2022 to 2025 period, dropped to KRW 40.2 billion in 2023, and reached KRW 64.3 billion in 2025, down 7.7%.
The gap between sales growth and margin compression was most visible in 2024, and in 2025, the year the Taxotere business was acquired, the debt-to-equity ratio rose from 48.4% to 64.1%.
Operating cash flow increased each year, from KRW 27.8 billion in 2022 to KRW 42.2 billion in 2023, KRW 80.6 billion in 2024 and KRW 133.2 billion in 2025.
Quarterly, fourth-quarter 2025 sales fell 12.4% from the prior quarter to KRW 245.3 billion and the company recorded an operating loss of KRW 649 million, a swing from profit.
First-quarter 2026 operating profit of KRW 20.2 billion turned positive, followed by KRW 23.8 billion in the second quarter (up 18.1% quarter on quarter) and KRW 25.5 billion in the third quarter (up 7.1%).
Third-quarter operating profit was still 13.4% lower than a year earlier, and press coverage attributed the decline partly to amortization of KRW 12.8 billion related to the Taxotere acquisition, up 122.0% year on year, along with higher labor and fee costs.
Financial income and expenses swung to a KRW 44.6 billion loss in the same quarter, mainly from foreign currency translation losses after the won weakened, which produced a net loss attributable to controlling shareholders of KRW 13.2 billion.
Net income attributable to controlling shareholders for the last four quarters (fourth quarter 2025 to third quarter 2026) totaled KRW 73.4 billion.